KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) FCF Margin (2016 - 2025)

Historic FCF Margin for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to 33.12%.

  • Gsk's FCF Margin rose 24300.0% to 33.12% in Q3 2025 from the same period last year, while for Dec 2025 it was 43.11%, marking a year-over-year increase of 208000.0%. This contributed to the annual value of 29.51% for FY2024, which is 71500.0% up from last year.
  • Gsk's FCF Margin amounted to 33.12% in Q3 2025, which was up 24300.0% from 33.67% recorded in Q2 2025.
  • In the past 5 years, Gsk's FCF Margin ranged from a high of 42.87% in Q3 2021 and a low of 7.48% during Q1 2023
  • For the 5-year period, Gsk's FCF Margin averaged around 25.18%, with its median value being 22.33% (2023).
  • Data for Gsk's FCF Margin shows a peak YoY increase of 295300bps (in 2021) and a maximum YoY decrease of -742600bps (in 2021) over the last 5 years.
  • Over the past 5 years, Gsk's FCF Margin (Quarter) stood at 36.36% in 2021, then plummeted by -44bps to 20.37% in 2022, then fell by -15bps to 17.24% in 2023, then grew by 27bps to 21.81% in 2024, then surged by 52bps to 33.12% in 2025.
  • Its FCF Margin stands at 33.12% for Q3 2025, versus 33.67% for Q2 2025 and 20.08% for Q1 2025.